Who qualifies for Wegovy?
Wegovy · semaglutide · by Novo Nordisk
Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.
FDA-approved for adults with BMI ≥30, or BMI ≥27 with a weight-related comorbidity (high blood pressure, prediabetes, sleep apnea, dyslipidemia). Also approved for adolescents 12+ at the 95th percentile BMI. Contraindicated in personal/family history of medullary thyroid cancer or MEN2.
Where to get Wegovy
Ro
from $145/mo- Best for insured patients
- Best for clinical oversight
Ro Body — branded GLP-1 weight care program
Hims
from $199/mo- Best for cash-pay
- Best for speed
Hims Weight Loss — compounded GLP-1 from $199/mo
Noom Med
from $179/mo- Best for coaching
- Best for maintenance
Noom Med — GLP-1 + behavioral psychology coaching
More on Wegovy
- How much does Wegovy cost?
- Wegovy side effects
- Wegovy dosing and titration schedule
- How does Wegovy work?
- Wegovy drug interactions
- Wegovy and pregnancy: safety, planning, breastfeeding
- Wegovy and alcohol: what to know
- Wegovy missed dose: what to do
- Wegovy savings: coupons, manufacturer programs, lower-cost options
- ← Full Wegovy overview
People also ask
Frequently asked
Am I eligible for Wegovy?+
FDA-approved for adults with BMI ≥30, or BMI ≥27 with a weight-related comorbidity (high blood pressure, prediabetes, sleep apnea, dyslipidemia). Also approved for adolescents 12+ at the 95th percentile BMI. Contraindicated in personal/family history of medullary thyroid cancer or MEN2.
Who should not take Wegovy?+
Anyone with the documented contraindications listed above. Always disclose full medical history, current medications, and family cancer history to the prescribing clinician.